Professor Olga Ciccarelli will deliver the MS Society’s fifth Annual Stop MS lecture online on Wednesday 7 October.
Almost 80% of people with sudden loss of smell or taste tested positive for Covid-19 antibodies, finds a new study by researchers at UCL and UCLH.
A feature in The Lancet Respiratory Medicine has shone a spotlight on the experience of the UCLH and UCL team that worked with Mercedes F1 engineers to develop a life-saving breathing aid at the height of the pandemic.
A study supported by the NIHR UCLH Biomedical Research Centre carried out at UCL has found that people who have experienced post-traumatic stress disorder (PTSD) are up to twice as likely to develop dementia later in life.
Almost 5,000 people have been recruited to Covid-19 research studies at UCLH since the pandemic began, with recruitment to studies continuing.
UCLH and UCL researchers featured prominently in AI in Health and Care Awards announced by NHSX and the NHR this week.
Elderly patients suffering the most common type of heart attack may benefit from more invasive treatment, new research involving UCLH has shown.
UCLH clinicians and researchers have launched a new ‘tele-otology’ service – the first of its kind in the UK that allows ENT surgeons to assess patients’ hearing and ear problems remotely and shorten treatment pathways.
UCL and UCLH researchers have published the first health economic model able to identify cost-effective innovative hearing loss treatments that can be adopted into hearing care.
UCL researchers have discovered how sleep is regulated differently in babies compared to adults.
A pioneering breast cancer therapy developed by UCLH and UCL, which requires just one shot of radiotherapy rather than conventional weeks-long treatment, has proven to be as effective for most women in treating the disease.
UCLH Biomedical Research Centre supported Consultant Infectious Diseases Physician Professor Sir Alimuddin (Ali) Zumla has been awarded the 2020 Mahathir Science Award, the most prestigious international science award presented in recognition for the best scientific work in solving priority health problems in the tropics.
A team at UCLH, UCL and Mercedes-AMG High Performance Powertrains who developed a Continuous Positive Airway Pressure (CPAP) breathing aid now used in hospitals across the UK have received an award from the Royal Academy of Engineering for exceptional services during a pandemic.
A cancer drug trialled for the first time in the world at the UCLH Clinical Research Facility (CRF) has been approved for use in patients in the United States.
Researchers from UCLH, UCL and the University of East Anglia have highlighted the need to identify, test and isolate healthcare workers who experience a new loss of taste or smell (anosmia).